cbdMD Inc. filed SEC Form 8-K: Other Events

false 0001644903 0001644903 2024-07-19 2024-07-19 0001644903 ycbd:CommonCustomMember 2024-07-19 2024-07-19 0001644903 ycbd:SeriesACumulativeConvertiblePreferredStock8CustomMember 2024-07-19 2024-07-19

 

 

 

 

Date of Report (Date of earliest event reported) July 19, 2024

 

 

 

 

 

Registrant's telephone number, including area code: (704) 445-3060

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

As of July 19, 2024, following the reconciliation of partial conversions of cbdMD, Inc.’s series of 8% Senior Secured Original Issue 20% Discount Convertible Promissory Notes (the “Notes”), the number of issued and outstanding shares of cbdMD, Inc. common stock is 3,763,433. The aggregate principal balance of the Notes outstanding as of July 19, 2024 is $1,076,963.

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.